← Open Payments lookup

MELANIE WAYNE: Open Payments

NPI 1912353657 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$514 in 17 payments from 10 companies in 2025. Trend: 2023 $3,133 · 2024 $677 · 2025 $514

Food & beverage: $514
CompanyPaymentsAmount
Blueprint Medicines Corporation1$131
Takeda Pharmaceuticals U.S.A., Inc.3$97
GlaxoSmithKline, LLC.2$56
Novartis Pharmaceuticals Corporation3$54
CSL Behring3$49
AstraZeneca Pharmaceuticals LP1$34
BioCryst US Sales Co., LLC1$30
Regeneron Healthcare Solutions, Inc.1$26
TerSera Therapeutics LLC1$20
GENZYME CORPORATION1$18

Products named: AYVAKIT, TAKHZYRO, TRELEGY ELLIPTA, Rhapsido, DUPIXENT, Hizentra, FASENRA, ORLADEYO.

Industry payments across OR — which companies pay providers there.